Biomed Israel 2026 Speakers - All Other Speakers To Be Announced Shortly
Co-Chairpersons
Ruti Alon
Founder and CEO
Medstrada
Read More
Plenary Speakers
Dr. Jeremy M. Levin, MD
Chairperson
Ovid Therapeutics Inc & Opthea
Read More
Prof. Yifat Merbl
Professor of Immunology
Weizmann Institute of Science
Read More
Philip Nelson
Director, Software Engineering
Google Research
Read More
Plenary: Genomics Meets AI: From Data to Decisions
Ariel Larey
AI Research Scientist
NVIDIA
Read More
Prof. Gideon Rechavi, MD
Founding Director, Cancer Research Center, Professor of Pediatrics and Human Molecular Genetics
Sheba Medical Center, Tel Aviv University
Read More
Plenary Investors Panel: Biotech Investing in a New Reality: What Gets Funded, What Doesn’t, and Why?
Mati Gill
CEO
AION Labs
Read More
Edward Kliphuis
Partner
Sofinnova Partners
Read More
Dr. Adam Koppel, MD, PhD
Partner
Bain Capital Life Sciences
Read More
Laura Lande-Diner, PhD
Managing Partner
Jefferson Life Sciences
Read More
Keynote Speakers
Michelle Lynn-Hall, PhD
Co-Founder & General Partner
Entrée Bioventures
Read More
Michael A. Margolis
Senior Managing Director, Head of Healthcare Investment Banking
Oppenheimer & Co
Read More
Prof. Gal Markel, MD, PhD, MBA
Director, Founder & Chairmen, Deputy CEO, Professor
The Davidoff Cancer Center, Samueli Cancer Institute, Rabin Medical Center, Tel Aviv University
Read More
Dan (Dong-Yul) Sung, PhD
Executive Vice President
ToolGen
Read More
Dr. Jonathan Weyne, MD
Vice President Ophthalmology Therapeutic
Regeneron
Read More
Company Presenters
Beyond Bones and Screws: Rethinking Orthopedic Repair
Dr. Assaf Dekel, MD
Chairman & CEO
OTS Medical
Read More
From Detection to Prediction: Diagnosing Disease Before Symptoms
The Future of Aging: Where Longevity Meets Innovation
Dr. Pablo Cabral, MD
Executive Director, External Innovation
Eli Lilly
Read More
The Device is No Longer a Device: Convergence in Medical Technology
Reinventing Clinical Trials: New Models, Technologies and Companies
The Next Pandemic: Are We Ready? Innovation in Infectious Diseases
Managing Cancer in an Era of Choice: Optimizing Outcomes
Beyond NeuroPharma and NeuroTech: Integrated Brain Control
Elisabeth Kogan
CEO & Co-Founder
Syremis Therapeutics
Read More
When Biology Becomes a Language: BioData Teaching
Rewriting Biology in Vivo: The Age of Cellular Reprogramming - The Next Frontiers in Genetic Medicine
Christian Dombrowski, PhD
Senior Vice President
Averna Therapeutics
Read More
Michelle Lynn-Hall, PhD
Co-Founder & General Partner
Entrée Bioventures
Read More
Engineering the Beating System: Biology Meets Technology
Prof. Chaim Lotan, MD
Professor of Internal Medicine (Cardiology), Director, Heart Institute
Hadassah-Hebrew University
Read More
Shaping the Future of Personalized Nutrition: Evidence-Driven Science Meets Real-World
Redefining the Fight Against Cancer: New Targets, New Modalities
Michael A. Margolis
Senior Managing Director, Head of Healthcare Investment Banking
Oppenheimer & Co
Read More
Prof. Gal Markel, MD, PhD, MBA
Director, Founder & Chairmen, Deputy CEO, Professor
The Davidoff Cancer Center, Samueli Cancer Institute, Rabin Medical Center, Tel Aviv University
Read More
Prof. Amnon Peled
Director of the Gene Therapy Institute
Hadassah – Hebrew University Medical Center
Read More
Gene Editing in Plants: CRISPR and Beyond
Dror Shalitin, PhD
Founder & CEO
PlantArcBio
Read More
Dan (Dong-Yul) Sung, PhD
Executive Vice President
ToolGen
Read More
Restoring Vision: Where Biology Meets Engineering
Dr. Jonathan Weyne, MD
Vice President Ophthalmology Therapeutic
Regeneron
Read More
AI as an Equalizer: From Center to Periphery in Healthcare
How AI Is Rewiring Pharma R&D: From Molecules to Models to Quantum Technology
